UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

Nature communications, 2023-01, Vol.14 (1), p.132-132, Article 132

2023

Volltextzugriff (PDF)

Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells

The Journal of immunology (1950), 2011-12, Vol.187 (11), p.6069-6081

2011

Volltextzugriff (PDF)

Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3353

2020

Volltextzugriff (PDF)

A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells

Molecules (Basel, Switzerland), 2018-01, Vol.23 (1), p.71

2018

Volltextzugriff (PDF)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis

FEBS open bio, 2023-09, Vol.13 (9), p.1601-1614

2023

Volltextzugriff (PDF)

Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection

Journal of leukocyte biology, 2018-03, Vol.103 (3), p.445-456

2018

Volltextzugriff (PDF)

Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11528

2022

Volltextzugriff (PDF)

New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease

International journal of molecular sciences, 2022-11, Vol.23 (22), p.14483

2022

Volltextzugriff (PDF)

GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease

International journal of molecular sciences, 2020-06, Vol.21 (12), p.4486

2020

Volltextzugriff (PDF)

miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases

Cancers, 2022-07, Vol.14 (14), p.3493

2022

Volltextzugriff (PDF)

Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators

Frontiers in pharmacology, 2018-07, Vol.9, p.719-719

2018

Volltextzugriff (PDF)

Early diagnosis from newborn screening maximises survival in severe cystic fibrosis

ERJ open research, 2018-04, Vol.4 (2), p.109

2018

Volltextzugriff (PDF)

Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in Pseudomonas aeruginosa Infection of Cystic Fibrosis Bronchial Epithelial Cells

Mediators of Inflammation, 2017-01, Vol.2017 (2017), p.1-16

2017

Volltextzugriff (PDF)

A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator ( CFTR ) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1

Biomedicines, 2021-01, Vol.9 (2), p.117

2021

Volltextzugriff (PDF)

Interaction of Adenovirus Type 5 Fiber with the Coxsackievirus and Adenovirus Receptor Activates Inflammatory Response in Human Respiratory Cells

Journal of Virology, 2006-11, Vol.80 (22), p.11241-11254

2006

Volltextzugriff (PDF)

Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells

International immunopharmacology, 2008-12, Vol.8 (12), p.1672-1680

2008

Volltextzugriff (PDF)

Molecular basis of cystic fibrosis: from bench to bedside

Annals of translational medicine, 2018-09, Vol.6 (17), p.334-334

2018

Volltextzugriff (PDF)

A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker

Journal of neuro-oncology, 2018, Vol.136 (1), p.51-62

2018

Volltextzugriff (PDF)

Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene

European journal of medicinal chemistry, 2021-01, Vol.209, p.112876, Article 112876

2021

Volltextzugriff (PDF)

Time Trends in Birth Incidence of Cystic Fibrosis in Two European Areas: Data from Newborn Screening Programs

The Journal of pediatrics, 2008, Vol.152 (1), p.25-32

2008

Volltextzugriff (PDF)

Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis

Glycoconjugate journal, 2020-10, Vol.37 (5), p.623-633

2020

Volltextzugriff (PDF)

β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model

Journal of cystic fibrosis, 2023-01, Vol.22 (1), p.156-160

2023

Volltextzugriff (PDF)

Association between carrier screening and incidence of cystic fibrosis

JAMA : the journal of the American Medical Association, 2009-12, Vol.302 (23), p.2573

2009

Volltextzugriff (PDF)

Circulating microRNAs as emerging non-invasive biomarkers for gliomas

Annals of translational medicine, 2017-07, Vol.5 (13), p.277-277

2017

Volltextzugriff (PDF)

Cystic fibrosis carrier screening effects on birth prevalence and newborn screening

Genetics in medicine, 2016-02, Vol.18 (2), p.145-151

2016

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(66)
Bücher
(1)

Sprache

Englisch
(67)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells

Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis

A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells

Cross‐talk between CFTR and sphingolipids in cystic fibrosis

Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection

Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening

New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease

GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease

miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases

Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators

Early diagnosis from newborn screening maximises survival in severe cystic fibrosis

Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in Pseudomonas aeruginosa Infection of Cystic Fibrosis Bronchial Epithelial Cells

A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator ( CFTR ) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1

Interaction of Adenovirus Type 5 Fiber with the Coxsackievirus and Adenovirus Receptor Activates Inflammatory Response in Human Respiratory Cells

Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells

Molecular basis of cystic fibrosis: from bench to bedside

A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker

Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene

Time Trends in Birth Incidence of Cystic Fibrosis in Two European Areas: Data from Newborn Screening Programs

Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis

β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model

Association between carrier screening and incidence of cystic fibrosis

Circulating microRNAs as emerging non-invasive biomarkers for gliomas

Cystic fibrosis carrier screening effects on birth prevalence and newborn screening

Suchergebnisse filtern